Gong-Ping Liu Huazhong University of Science and Technology Wuhan (China)
Gong-Ping Liu received his PhD in Labor and environmental health from Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China. He then received postdoctoral training in the laboratory of Prof. Jian-Zhi Wang during which he focused on the molecular mechanisms and gene therapy for neurodegenerative disorders. Dr. Liu joined the Pathophysiology faculty at Huazhong University of Science and Technology as a lecturer in 2008. In 2013, he was hired as a professor at Huazhong University of Science and Technology of the Pathophysiology faculty.
Shaohua Wang Zhongda Hospital of Southeast University Nanjing (China)
Shaohua Wang is a Chief Physician and a Professor at the Department of Endocrinology at ZhongDa Hospital of Southeast University. He received his M.D. in Clinical Medicine from Nanjing Railway Medical College and Ph.D. in Internal Medicine from Medical School of Southeast University. Professor Wang is an Associate Editor of “Journal of Alzheimer’s Disease”. He has published more than 50 academic papers in the scientific database. His research is primarily focused on the basic and clinical study of diabetic associated-cognitive impairment, prevention and treatment strategies of diabetic chronic complications as well as prevention and early intervention strategies of gestational diabetes mellitus. He is currently working to provide additional insights into the pathogenesis of T2DM-related cognitive impairment and an early therapeutic strategy to treat dementia.
Huafeng Wei Department of Anesthesiology and Critical Care, Perelman School of Medicine University of Pennsylvania Philadelphia, PA (USA)
Dr. Huafeng Wei is an Associate Professor with Tenure
at the Department of Anesthesiology at the University of
Pennsylvania in the U.S.A. Dr. Wei completed his
medical graduate student education and training in
Anesthesiology at Tongji Medical University in 1988. He
obtained his Ph.D. in pharmacology and toxicology from
the George Washington University in 1996 and
completed his postdoctoral training at Georgetown
University and National Institute of Health (NIH) in 1999.
He completed his second resident training in
Anesthesiology and Critical Care at the University of Pennsylvania in 2003 and become
a standing faculty member thereafter at UPENN. His lab has focused on studying the
role of calcium dysregulation in neurodegeneration in various neurodegenerative
diseases, especially in Alzheimer’s disease and after various general anesthetics
treatments. His lab is the first to demonstrate that dantrolene, a drug for treatment of
malignant hyperthermia, can abolish the memory and learning impairment in various
animal models of Alzheimer’s disease. Dr. Wei has been an invited speaker for Harvard,
Johns Hopkins, UCSF, Duke, UVA, Imperial College of England, University of
Heidelberg in Germany, University of Padova in Italy, as well as speakers for
international conferences in more than 10 countries and regions.
Shengzhou Wu Wenzhou Medical University Wenzhou (China)
Prof. Shengzhou Wu received a degree of bachelor of Medicine from
Shanghai Medical University (renamed as Shanghai Medical College of
Fudan University in 2000) and obtained a Ph.D degree in Neuroscience from
University of Arkansas for Medical Science. After a postdoctoral fellowship in
Department of Neurology in Washington University School of Medicine in St
Louis he has joined and currently is a professor in School of Optometry and
Ophthalmology, Wenzhou Medical University in China. His major scientific
interest is focused on neurodegeneration in the central nervous system and in
the retina including Alzheimer's disease.
Prof. Debomoy K. Lahiri (16607 citations) Neuroscience Research Center Indianapolis, IN 46202 (USA) Biography
Biography of Debomoy K. Lahiri
Dr. Debomoy Lahiri is Professor at Indiana University School of Medicine, USA. His major research focus is to understand the mechanism of aging, origin and biogenesis of the amyloid plaque, and to discover drug targets for Alzheimer's disease (AD) and other brain disorders. Dr. Lahiri’s group has shown the novel role of specific microRNA species in regulation of genes implicated in AD as well as the role of gene and environment interaction in late-life disorders. Also, his team has made significant contributions to understanding the biochemical pathway for neurodevelopment disorders, such as autism and fragile X syndrome. Dr. Lahiri is the Editor-In-Chief of the international journal, ‘Current Alzheimer Research' (Bentham). He authored books, such as ‘Protective Strategies for Neurodegenerative Diseases' published by the New York Academy of Sciences. Dr. Lahiri was awarded grants as a Principal Investigator from the National Institute on Aging, NIH, and Alzheimer’s Association, USA. His other honors include the ‘Zenith Award’ and listing in Marquis' ‘Who's Who in the World'.